Transaction · 0001437749-26-032421

Degnan Chris

Degnan Chris, CFO, reported an open-market or private sale at UroGen Pharma Ltd. involving 2202.000000 shares for an estimated $80791.38. Reported holdings after the transaction were 4561.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCFO
URGNUroGen Pharma Ltd.
Filing timeOct 09
Trade dateOct 08, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded32.56%Shares sold ÷ (holdings after + shares sold). Estimated position before: 6,763 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$36.97
Pre-filing
1mo ago +18.5%1w ago +9.7%1d ago +10.1%
Returns since
7d30d90d180d1y

URGN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
URGN since 2026-10-09Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-032421
Ordinary Shares
Transaction date
Oct 08, 2026
Filed Oct 09, 2026, 04:57 PM · 1d delay
Shares
2.20k sh
$36.69 per share
Estimated value
-$80.7k
Computed from shares × price
Holdings after
4.56k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

  2. F2

    Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

  3. F3

    The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.

Original filing · 0001437749-26-032421
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

URGN